Characterization of glucagon-like peptide 2 pathway member expression in bovine gastrointestinal tract.
Glucagon-like peptide 2 (GLP-2), secreted by enteroendocrine cells, has several physiological effects on the intestine of monogastric species, including promotion of growth of intestinal epithelium, reduction of epithelial cell apoptosis, and enhancement of intestinal blood flow, nutrient absorption, and epithelial barrier function. The regulatory functions of GLP-2 in the ruminant gastrointestinal tract (GIT) have not been well studied. The objectives of this investigation were to characterize the mRNA expression of 4 members of the GLP-2 pathway throughout the bovine GIT, including (1) proglucagon (GCG), the parent peptide from which GLP-2 is derived through cleavage by prohormone convertase; (2) prohormone convertase (PCSK1); (3) GLP-2 receptor (GLP2R); and (4) dipeptidyl peptidase IV (DPP4), the enzyme that inactivates GLP-2. Gene expression was evaluated in rumen, reticulum, omasum, abomasum, duodenum, jejunum, ileum, cecum, and rectum collected at slaughter from prepubertal heifers, mature cows in early, mid, and late lactation, and nonlactating cows (n=3 per stage) by a gene expression profiling assay. In addition, mRNA expression of 14 genes involved in nutrient transport, enzyme activity, blood flow, apoptosis, and proliferation were evaluated in the 9 GIT tissues for their association with GCG and GLP2R mRNA expression. Immunohistochemistry was used to localize GLP2R protein in tissues of the lower GIT. Results indicated that mRNA expression of GCG, PCSK1, GLP2R, and DPP4 varies across the 9 GIT tissues, with greatest expression in small and large intestines, and generally nondetectable levels in forestomachs. Expression of DPP4 and GLP2R mRNA varied by developmental stage or lactational state in intestinal tissues. Expression of GCG or GLP2R mRNA was correlated with molecular markers of proliferation, apoptosis, blood flow, enzyme activity, and urea transport, depending on the tissue examined, which suggests a potential for involvement of GLP-2 in these physiological processes in the ruminant GIT. The GLP2R protein was expressed in intestinal crypts of the bovine GIT, which is consistent with the distribution in monogastric species. Our findings support a functional role of the GLP-2 pathway in bovine GIT and the potential for use of GLP-2 as a therapy to improve intestinal function and nutrient absorption in ruminants.
Beltsville Agricultural Research Center, USDA-ARS, Beltsville, MD 20705, USA. erin.connor@ars.usda.gov
E E
EE
Connor
R L
RL
Baldwin
A V
AV
Capuco
C M
CM
Evock-Clover
S E
SE
Ellis
K S
KS
Sciabica
D000818:Animals; D002417:Cattle / Q000235:genetics / Q000378:metabolism*; D018819:Dipeptidyl Peptidase 4 / Q000235:genetics; D041981:Gastrointestinal Tract / Q000378:metabolism*; D015870:Gene Expression; D053767:Glucagon-Like Peptide 2 / Q000378:metabolism*; D000067758:Glucagon-Like Peptide-2 Receptor; D052336:Proglucagon / Q000235:genetics; D043484:Proprotein Convertases / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism*; D018027:Receptors, Glucagon / Q000235:genetics; D013279:Stomach, Ruminant / Q000378:metabolism
D053767:Glucagon-Like Peptide 2; D000067758:Glucagon-Like Peptide-2 Receptor; D012333:RNA, Messenger; D018027:Receptors, Glucagon; D052336:Proglucagon; D018819:Dipeptidyl Peptidase 4; D043484:Proprotein Convertases